Sponsored by:

Molecular Imaging: Page 472

Mallinckrodt scores Premier deals
By AuntMinnie.com staff writers
Mallinckrodt has received agreements for five of its imaging products from group purchasing organization Premier Purchasing Partners.
January 3, 2007
Temporal subtraction technique improves diagnostic accuracy, speed
By Jonathan S. Batchelor
Although bone scintigraphy is one of the more widely used nuclear medicine studies, interpreting the images is time-intensive, and detecting interval changes can be problematic. Now researchers from Chicago have developed a computerized temporal subtraction technique used between successive whole-body bone scans that may reduce physicians' reading time and improve their accuracy.
January 3, 2007
Siemens finalizes Bayer buy
By AuntMinnie.com staff writers
Siemens Medical Solutions has completed its acquisition of Bayer Healthcare's diagnostic division.
January 2, 2007
Philips, Bioscan partner on NanoSPECT marketing
By AuntMinnie.com staff writers
Philips Medical Systems has signed an agreement giving it the rights to co-market and co-distribute molecular imaging developer Bioscan's NanoSPECT and NanoSPECT/CT devices.
January 1, 2007
ART, GE extend eXplore Optix pact
By AuntMinnie.com staff writers
Canadian optical molecular imaging developer ART Advanced Research Technologies (ART) and GE Healthcare of Chalfont St. Giles, U.K., have extended their current agreement for GE to be the exclusive worldwide distributor of ART's eXplore Optix preclinical optical molecular imaging system.
December 21, 2006
Trial date set for IBA, Optivus dispute
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Application (IBA) is reporting that a trial date has been set in Los Angeles on the remaining claims asserted against IBA by Optivus Technology of Loma Linda, CA, and Loma Linda University Medical Center.
December 20, 2006
GE installs first Discovery STE in Canada
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K,. has completed the first installation of its Discovery STE PET/CT technology in Canada.
December 20, 2006
Siemens, UCLA to test Alzheimer's PET agent
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, announced today that it plans to begin clinical trials in collaboration with the University of California, Los Angeles, on a new biomarker based on PET technology that could potentially identify Alzheimer's disease before the onset of symptoms.
December 20, 2006
Mayo team refines scintimammography camera design
By Brian Casey
December 18, 2006
Solid-state dual-head camera supercharges molecular breast imaging
By Jonathan S. Batchelor
Molecular breast imaging's potential for detecting malignant tumors has been constrained by different factors, such as the limitation of conventional scintimammography with Tc-99m sestamibi in detecting smaller malignant tumors. But Mayo Clinic researchers may have overcome these drawbacks by developing a solid-state dual-head gamma camera for breast imaging.
December 18, 2006
PET reveals limbic dysfunction in mesial temporal lobe epilepsy
By Paula Moyer
Patients with mesial temporal lobe epilepsy (MTLE) who have an abnormal odor perception may have widespread limbic dysfunction, according to a presentation by Swedish investigators at the North American Regional Epilepsy Congress in San Diego earlier this month.
December 18, 2006
MDS Nordion shows Q4 revenue downturn, year-end upturn
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion, a division of Toronto-based MDS, reported a decrease in revenues for its fiscal 2006 fourth quarter (end-October 31), although the fiscal year showed positive growth.
December 13, 2006
Previous Page
Page 472 of 615
Next Page